RE:Growth investment in Accuhealth All equity deal, with the $200M to be invested over the next 3 years as Accuhealth pursues acquisitions.
Accuhealth is generating revenue of $30-$50 million.
The company has 300 customers, consisting of mid-to-large physician practises and health systems.
Accuhealth's closest competitors include Commure and Optimize Health.
Athenahealth launched a chronic care management platform to augment its RPM capabilities last year.
Respiratory health monitoring startup Aluna in January inhaled $15.3 million in Series B capital.
Biofourmis last year collected $300 million in Series D funding led by General Atlantic with participation from CVS Health and others at a valuation of roughly $1.3 billion.
"There are a lot of players in the [RPM] space, which is highly fragmented with no one taking the lead."